Akso Health Group Sponsored ADR AHG

0.75 (0.01) (1.32%) as of 25 Sep
Market cap
$649.1M
P/E
0.0×

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Sep '25 Sep '24 Sep '23 Mar '23 Older periods
Net Income
(19.18) (17.06) (24.39) (30.24)

+8 more TTM periods

Depreciation & Amortization
1.66 0.61 — —
Non Cash Items (Other)
(5.65) (1.43) 0.33 —
Accounts Receivable Change
(2.38) (8.08) (8.14) —
Income tax paid
0.21 (9.36) 5.34 —
Change in other assets and liabilities
1.06 (3.63) (1.24) 4.39
Operating Cash Flow
(5.35) (7.92) (12.44) (11.88)
Capital expenditures
(177.19) (1.59) — —
Net Aquisitions
— (57.71) — —
Short Term Investments Change (Net)
— — (56.31) —
Other investing activities
33.83 — — —
Investing cash flow
(222.47) (36.05) 10.61 (1.02)
Repayment/Issuance of Debt (Net)
— (22.31) (27.66) (8.01)
Other financial activities
— 87.15 — 24.27
Financing cash flow
— 39.56 (2.43) 6.52
Exchange Rate Adjustment
(2.61) (8.08) (2.51) —
Change in Cash
(157.63) (4.46) (3.91) 27.24
Beginning Cash
291.25 247.65 181.70 —
Ending Cash
122.72 168.96 210.22 —
Dividends Paid (Common)
0.00 0.00 0.00 —
Assets Liabilities Change (Total)
3.78 (9.42) 15.17 —
Investments Change (Net)
— — (72.81) —

Fold the line items

In millions of $ except per-share values · columns are period end dates